Article
Variation of mutant allele frequency in NRAS Q61 mutated melanomas.
BMC dermatology - 1 Jul 2017
Hélias-Rodzewicz Zofia, Funck-Brentano Elisa, Terrones Nathalie, Beauchet Alain, Zimmermann Ute, Marin Cristi, Saiag Philippe, Emile Jean-François
Abstract excerpt
BACKGROUND: Somatic mutations of BRAF or NRAS activating the MAP kinase cell signaling pathway are present in 70% of cutaneous melanomas. The mutant allele frequency of BRAF V600E (M%BRAF) was recently shown to be highly heterogeneous in melanomas. The present study focuses on the NRAS Q61 mutant allele frequency (M%NRAS). METHODS: Retrospective quantitative analyze of 104 NRAS mutated melanomas was performed...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
